Literatur
-
1
Berlin J, Catalano P, Thomas J. et al .
A Phase III Study of Gemcitabine in Combination with 5-FU vs.
Gemcitabine Alone in Patients with Advanced Pancreatic Carcinoma (E2297): an
Eastern Cooperative Oncology Group (ECOG) Trial.
Proceedings
ASCO.
2001;
20
127a
-
2
Bramhall S R, Rosemurgy A, Brown P D, Bowry C, Buckels J A. Marimastat Pancreatic Cancer Study Group .
Marimastat as first-line therapy for patients with
unresectable pancreatic cancer: a randomized trial.
J Clin
Oncol.
2001;
19
3445-3446
-
3
Bramhall S R, Schulz J, Nemunaitis J, Brown P D, Baillet M, Buckels J A.
A double-blind placebo-controlled, randomised study comparing
gemcitabine and marimastat with gemcitabine an placebo as first line therapy in
patients with advanced pancreatic cancer.
Br J
Cancer.
2002;
87
161-167
-
4
Burris H A, Moore M J, Andersen J. et al .
Improvements in survival and clinical benefit with
gemcitabine as first-line therapy for patients with advanced pancreas cancer: a
randomized trial.
J Clin
Oncol.
1997;
15
2403-13
-
5
Glimelius B, Hoffman K, Sjoden P O, Jacobsson G, Sellstrom H, Enander L K, Linne T, Svensson C.
Chemotherapy improves survival and quality of life in
advanced pancreatic and biliary cancer.
Ann
Oncology.
1996;
7
593-600
-
6
Lutz M P, Ducreux M, Wagner T. et al .
Docetaxel/gemcitabine or docetaxel/cisplatin in
advanced pancreatic carcinoma: a randomised phase II study of the EORTC-GI
group.
Proceedings
ASCO.
2002;
21
125a
-
7
Neoptolemos J P, Dunn J A, Stocken D D. et al .
Adjuvant chemoradiotherapy and chemotherapy in resectable
pancreatic cancer: a randomised controlled
trial.
Lancet.
2001;
358
1576-1585
-
8
Scheithauer W, Schüll B, Ulrich-Pur H. et al .
Biweekly high-dose gemcitabine alone or in combination with
capecitabine in patients with metastatic pancreatic adenocarcinoma: a
randomized phase II trial.
Ann
Oncology.
2003;
14
97-104
-
9
Schmidt C, Fahlke J, Kettner E. et al .
Phase II multicenter study of gemcitabine and docetaxel in
patients with inoperable or metastatic pancreatic cancer.
Proceedings
ASCO.
2002;
21
145a
-
10
Van Cutsem E, Karasek P, Oettle H. et al .
Phase III trial comparing gemcitabine + R115777
(Zarnestra) versus gemcitabine + placebo in advanced pancreatic cancer
(PC).
Proceedings
ASCO.
2002;
21
130a
Priv.-Doz. Dr. Manfred P. Lutz
Medizinische Klinik, Caritasklinik St. Theresia
Rheinstraße 2
66113 Saarbrücken
Telefon: 0681/4061001
Fax: 0681/4061003
eMail: m.lutz@caritasklinik.de
